BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain T, Dudeja V. The war against pancreatic cancer in 2020 - advances on all fronts. Nat Rev Gastroenterol Hepatol 2021;18:99-100. [PMID: 33414515 DOI: 10.1038/s41575-020-00410-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin X, Ye L, Wang X, Liao Z, Dong J, Yang Y, Zhang R, Li H, Li P, Ding L, Li T, Zhang W, Xu S, Han X, Xu H, Wang W, Gao H, Yu X, Liu L. Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. Cancers (Basel) 2021;13:3678. [PMID: 34359579 DOI: 10.3390/cancers13153678] [Reference Citation Analysis]
2 Yuan H, Liu J, Zhao L, Wu P, Chen G, Chen Q, Shen P, Yang T, Fan S, Xiao B, Jiang K. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Front Immunol 2021;12:800268. [PMID: 34956238 DOI: 10.3389/fimmu.2021.800268] [Reference Citation Analysis]
3 Fang K, Qu H, Wang J, Tang D, Yan C, Ma J, Gao L. Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer. Front Genet 2021;12:702072. [PMID: 34603372 DOI: 10.3389/fgene.2021.702072] [Reference Citation Analysis]
4 Matiash K, Lewis CS, Bogdanov VY. Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update. Cancers (Basel) 2021;13:4652. [PMID: 34572880 DOI: 10.3390/cancers13184652] [Reference Citation Analysis]
5 Liu Y, Liu L, Zhang Y, Qin L. S-Adenosylmethionine enhances the inhibitory effect of gemcitabine against pancreatic cancer cells via suppression of the EGFR/AKT pathways. Mol Cell Toxicol . [DOI: 10.1007/s13273-021-00220-y] [Reference Citation Analysis]
6 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
7 Jung JY, Ryu HJ, Lee SH, Kim DY, Kim MJ, Lee EJ, Ryu YM, Kim SY, Kim KP, Choi EY, Ahn HJ, Chang S. siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model. Cells 2021;10:2734. [PMID: 34685714 DOI: 10.3390/cells10102734] [Reference Citation Analysis]
8 Alain C, Pascal N, Valérie G, Thierry V. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target. Molecules 2021;26:4849. [PMID: 34443437 DOI: 10.3390/molecules26164849] [Reference Citation Analysis]
9 Choi AR, Feller ER. Misrepresentation of mild traumatic brain injury research in press releases. PM R 2021. [PMID: 34156765 DOI: 10.1002/pmrj.12656] [Reference Citation Analysis]
10 Li J, Yu N, Li X, Cui M, Guo Q. The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer. Front Oncol 2021;11:759894. [PMID: 34745998 DOI: 10.3389/fonc.2021.759894] [Reference Citation Analysis]
11 Lee K, Oh HJ, Kang MS, Kim S, Ahn S, Kim MJ, Kim SW, Chang S. Metagenomic analysis of gut microbiome reveals a dynamic change in Alistipes onderdonkii in the preclinical model of pancreatic cancer, suppressing its proliferation. Appl Microbiol Biotechnol 2021;105:8343-58. [PMID: 34648062 DOI: 10.1007/s00253-021-11617-z] [Reference Citation Analysis]
12 Vaish U, Jain T, Are AC, Dudeja V. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Int J Mol Sci 2021;22:13408. [PMID: 34948209 DOI: 10.3390/ijms222413408] [Reference Citation Analysis]